| Literature DB >> 35048250 |
Inés Picó-Sirvent1, Agustín Manresa-Rocamora1,2, Adolfo Aracil-Marco3,4, Manuel Moya-Ramón1,2.
Abstract
PURPOSE: There is no consensus on the best exercise recommendation for women affected by severe obesity while they are waiting for bariatric surgery. For this reason, the effects of a combination of aerobic exercise performed at the intensity at which maximal fat oxidation is reached (Fatmax) with low-intensity resistance training were studied.Entities:
Mesh:
Year: 2022 PMID: 35048250 PMCID: PMC8933381 DOI: 10.1007/s11695-022-05897-1
Source DB: PubMed Journal: Obes Surg ISSN: 0960-8923 Impact factor: 4.129
Fig. 1Study flowchart (
adapted from CONSORT 2010 Flow Diagram)
Baseline participant characteristics
| EG ( | CG ( | ||
|---|---|---|---|
| Age (years) | 43 ± 5 | 42 ± 9 | 0.725 |
| Weight (kg) | 125.3 ± 13.9 | 115.8 ± 15.1 | 0.161 |
| Postmenopausal (yes) | 2 (20) | 2 (20) | 0.999 |
| Medication (yes) | 5 (50) | 4 (40) | 0.653 |
| Diabetes (yes) | 3 (30) | 2 (20) | 0.606 |
| Smoker (yes) | 1 (10) | 1 (10) | 0.166 |
Data are shown as number of cases (percentage) or mean ± SD. p values refer to differences between groups. EG experimental group, CG control group
Physical activity program schedule
| Type of exercise | Month | |||
|---|---|---|---|---|
| 1 | 2 | 3 | ||
| CAT at Fatmax | Weekly frequency (sessions/week) | 2 | 2 | 2 |
| Volume (min) | 40 | 50 | 60 | |
| Intensity (W) | Fatmax | Fatmax | Fatmax | |
| Resistance training | Weekly frequency (sessions/week) | 2 | 1 | 2 |
| Volume (series × exer. × rep.) | 2 × 5 × 20 20 | 3 × 8 × 30 50 | 4 × 8 × 30 60 | |
| Volume (min) | ||||
| Intensity (%1RM) | 20 | 25 | 30 | |
| Stretching training | Weekly frequency (sessions/week) | 2 | 3 | 4 |
| Volume (series × exer.) | 1 × 5 | 1 × 5 | 1 × 5 | |
| Duration (min) | 1 | 1 | 1 | |
CAT continuous aerobic training, Fatmax intensity at which maximal fat oxidation is registered, min minutes, W watts, exer. × rep. number of exercises performed and number of repetitions per exercise, %1RM percentage over a maximum repetition
Effect of the intervention on anthropometric measurements
| Experimental ( | Change | Control ( | Change | ANOVA (interaction) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Variables | Pre | Post | Pre | Post | |||||||
| BMI (kg·m−2)& | 48.7 ± 5.5 | 47.8 ± 5.9 | 0.071 | − 0.86 | 44.2 ± 5.7 | 43.9 ± 5.2 | 0.540 | − 0.28 | 0.837 | 0.372 | 4.4 |
| Weight (kg) | 125.3 ± 13.9 | 123.1 ± 14.8 | 0.078 | − 0.84 | 115.8 ± 15.1 | 114.9 ± 13.9 | 0.497 | − 0.31 | 0.690 | 0.417 | 3.7 |
| EBW (kg) | 60.9 ± 13.6 | 58.6 ± 14.4 | 0.078 | − 0.84 | 50.2 ± 14.4 | 49.4 ± 13.2 | 0.497 | − 0.31 | 0.690 | 0.417 | 3.7 |
| EBW (%) | 48.1 ± 5.8 | 47.1 ± 6.2 | 0.060 | − 0.90 | 42.7 ± 6.8 | 42.4 ± 6.4 | 0.565 | − 0.26 | 1.010 | 0.328 | 5.3 |
| Fat mass (kg)& | 66.3 ± 8.3 | 63.8 ± 8.5 | 0.006* | − 1.37 | 58.9 ± 8.8 | 58.6 ± 8.6 | 0.718 | − 0.16 | 3.729 | 0.069 | 17.2 |
| Fat mass (%) | 52.9 ± 1.8 | 51.8 ± 2.2 | 0.015* | − 1.20 | 50.8 ± 2.4 | 50.8 ± 2.5 | 0.839 | 0.09 | 4.160 | 0.056 | 18.8 |
| FFM (kg) | 58.9 ± 6.3 | 59.2 ± 7.2 | 0.782 | 0.13 | 56.9 ± 7.5 | 56.3 ± 6.3 | 0.491 | − 0.31 | 0.484 | 0.496 | 2.6 |
| FFM (%) | 47.1 ± 1.8& | 48.1 ± 2.2 | 0.015* | 1.20 | 49.2 ± 2.4 | 49.1 ± 2.5 | 0.839 | − 0.09 | 4.160 | 0.056 | 18.8 |
| Waist (cm)& | 142 ± 14 | 140 ± 15 | 0.334 | − 0.44 | 134 ± 16 | 134 ± 15 | 0.719 | − 0.16 | 0.197 | 0.663 | 1.1 |
| Hip (cm) | 147 ± 11 | 146 ± 14 | 0.410 | − 0.38 | 140 ± 14 | 139 ± 13 | 0.633 | − 0.22 | 0.064 | 0.803 | 0.4 |
| WHR (cm)a | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.721 | − 0.16 | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.929 | − 0.04 | 0.037 | 0.850 | 0.2 |
| Visceral fat (%)& | 17.8 ± 2.5 | 17.2 ± 2.5 | 0.013* | − 1.23 | 15.6 ± 2.9 | 15.3 ± 2.7 | 0.189 | − 0.61 | 0.944 | 0.344 | 0.5 |
BMI body mass index, EBW excess body weight, FFM fat-free mass, WHR waist-to-hip ratio. Data at pre- and post-intervention are delivered as mean ± SD
&Data were log-transformed before performing the ANOVA
aNon-normally distributed data
Effect of the intervention on resting metabolic rate and substrate oxidation
| Experimental ( | Change | Control ( | Change | ANOVA (interaction) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Variables | Pre | Post | Pre | Post | |||||||
| RCHO (g·min−1)& | 0.121 ± 0.06 | 0.122 ± 0.05 | 0.851 | 0.09 | 0.102 ± 0.08 | 0.143 ± 0.08 | 0.008* | 1.35 | 3.969 | 0.062 | 18.1 |
| RCHO (g·day−1)& | 173.3 ± 81.4 | 175.0 ± 67.7 | 0.826 | 0.10 | 146.1 ± 119.1 | 206.7 ± 110.5 | 0.006* | 1.38 | 4.098 | 0.058 | 18.5 |
| RCHO (%) | 53.2 ± 20.9 | 53.7 ± 14.4 | 0.932 | 0.04 | 51.6 ± 26.3 | 62.7 ± 18.5 | 0.067 | 0.87 | 1.738 | 0.204 | 8.8 |
| RFO (g·min−1) | 0.088 ± 0.03 | 0.092 ± 0.03 | 0.685 | 0.18 | 0.070 ± 0.033 | 0.065 ± 0.03 | 0.612 | − 0.23 | 0.432 | 0.520 | 2.3 |
| RFO (%) | 46.7 ± 20.9 | 46.3 ± 14.4 | 0.932 | − 0.04 | 48.3 ± 26.3 | 37.2 ± 18.5 | 0.067 | − 0.87 | 1.738 | 0.204 | 8.8 |
| RFOBW | 0.710 ± 0.26 | 0.731 ± 0.19 | 0.804 | 0.11 | 0.622 ± 0.28 | 0.630 ± 0.20 | 0.924 | 0.04 | 0.012 | 0.913 | 0.1 |
| RFOFFM | 1.5 ± 0.5 | 1.5 ± 0.3 | 0.964 | 0.02 | 1.2 ± 0.5 | 1.2 ± 0.3 | 0.852 | 0.08 | 0.010 | 0.921 | 0.1 |
| RFO (g·day−1) | 128.6 ± 49.6 | 130.5 ± 40.1 | 0.895 | 0.06 | 98.3 ± 49.1 | 97.0 ± 41.1 | 0.928 | − 0.04 | 0.025 | 0.875 | 0.1 |
| RMR (kcal) | 1869 ± 406 | 1894 ± 336 | 0.827 | 0.10 | 1480 ± 474 | 1695 ± 270 | 0.073 | 0.85 | 1.414 | 0.250 | 7.3 |
| RMRBW (kcal) | 14.8 ± 2.5 | 15.3 ± 2.0 | 0.582 | 0.25 | 12.42 ± 3.2 | 14.4 ± 1.8 | 0.040* | 0.99 | 1.359 | 0.259 | 7.0 |
| RMRFFM (kcal) | 31.7 ± 6.1 | 32.0 ± 4.6 | 0.859 | 0.08 | 24.6 ± 5.4 | 29.2 ± 3.7 | 0.029* | 1.06 | 2.407 | 0.138 | 11.8 |
RCHO resting carbohydrate oxidation, RFO resting fat oxidation, RMR resting metabolic rate, BW body weight, FFM fat-free mass. Data at pre- and post-intervention are delivered as mean ± SD
&Data were log-transformed before performing the ANOVA
aNon-normally distributed data
Fig. 2Individual data values of resting fat oxidation (RFO; A and B), and maximal fat oxidation at exercise (MFO; C and D). Left panels (filled circles) correspond to the control group. Right panels (open circles) correspond to the experimental group. Pre- and post- indicate that the measurement was taken before or after the intervention, respectively. The clear trend of increasing MFO specifically in the experimental group (D) can be seen. N.S: non-significant differences; *p < 0.05. For the mean and SD values, please see Tables 4 and 5
Effect of the intervention on cardiorespiratory fitness and substrate oxidation during exercise
| Experimental ( | Change | Control ( | Change | ANOVA (interaction) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Variables | Pre | Post | Pre | Post | |||||||
| VO2peak abs (L·min−1) | 1.8 ± 0.4 | 1.9 ± 0.4 | 0.073 | 0.85 | 1.7 ± 0.2 | 1.8 ± 0.2 | 0.265 | 0.51 | 0.281 | 0.602 | 1.5 |
| VO2peak abs/BW (mL*BW−1·min−1) | 14.6 ± 3.2 | 15.7 ± 2.8 | 0.166 | 0.65 | 21.6 ± 8.4 | 22.6 ± 8.7 | 0.204 | 0.59 | 0.008 | 0.931 | 0.0 |
| VO2peak abs/FFM (mL*FFM−1·min−1) | 31.1 ± 6.5 | 32.7 ± 5.4 | 0.119 | 0.73 | 25.2 ± 9.4 | 26.3 ± 9.7 | 0.262 | 0.52 | 0.114 | 0.739 | 0.6 |
| POpeak (W) | 127 ± 41 | 148 ± 46 | < 0.001* | 2.36 | 146 ± 23 | 148 ± 25 | 0.621 | 0.22 | 11.400 | 0.003* | 38.8 |
| VT2 (W)a | 104.4 ± 24.1 | 128.6 ± 39.6 | 0.001* | 1.82 | 98.5 ± 17.1 | 114.0 ± 18.9 | 0.018* | 1.17 | 1.013 | 0.328 | 5.6 |
| VO2peak abs/BW at VT2 (L·min−1) | 12.5 ± 2.7 | 13.8 ± 3.7 | 0.064 | 0.93 | 11.8 ± 1.9 | 13.6 ± 1.1 | 0.011* | 1.27 | 0.270 | 0.610 | 1.6 |
| MFO (g·min−1) | 0.187 ± 0.068 | 0.239 ± 0.080 | 0.025* | 1.10 | 0.170 ± 0.074 | 0.171 ± 0.063 | 0.963 | 0.02 | 2.888 | 0.106 | 13.8 |
| MFOBW (mg·kg−1·min−1) | 1.4 ± 0.4 | 1.9 ± 0.6 | 0.020* | 1.14 | 1.4 ± 0.6 | 1.4 ± 0.4 | 0.922 | − 0.04 | 3.522 | 0.077 | 16.4 |
| MFOFFM (mg·kg−1·min−1) | 3.1 ± 0.9 | 4.0 ± 1.2 | 0.044* | 1.21 | 2.9 ± 1.1 | 2.9 ± 0.9 | 0.790 | 0.14 | 2.867 | 0.108 | 13.7 |
| Fatmax (W)a | 37.1 ± 10.2 | 49.2 ± 12.7 | < 0.001* | 2.15 | 42.2 ± 9.3 | 38.7 ± 9.5 | 0.181 | − 0.62 | 19.223 | < 0.001* | 51.6 |
| PO at Fatmax (%) | 23.5 ± 5.3 | 31.6 ± 7.0 | < 0.001* | 2.40 | 26.1 ± 5.6 | 24.6 ± 5.5 | 0.320 | − 0.46 | 20.440 | < 0.001* | 53.2 |
| VO2peak at Fatmax (%)a | 54.9 ± 8.8 | 55.9 ± 7.2 | 0.679 | 0.19 | 50.9 ± 8.0 | 50.9 ± 9.1 | 0.955 | − 0.03 | 0.114 | 0.739 | 0.6 |
| HR at Fatmax (%) | 77.1 ± 7.9 | 79.6 ± 6.8 | 0.347 | 0.43 | 71.9 ± 12.7 | 71.8 ± 7.5 | 0.967 | − 0.02 | 0.508 | 0.485 | 2.7 |
VO oxygen uptake, PO power output, MFO maximal fat oxidation, Fatmax intensity at which maximal fat oxidation was reached, HR heart rate, BW body weight, FFM fat-free mass, VT2 second ventilatory threshold. Data at pre- and post-intervention are delivered as mean ± SD
&Data were log-transformed before performing the ANOVA
aNon-normally distributed data